Written by: Christian Boettcher Orthobond received on April 5th de novo approval for the company’s spinal fusion device with quaternary ammonium compound coating. Orthobond’s antibacterial... Read More
Written by: Paige L. Cappelli The inaugural AAMI/FDA neXus medical device standards conference was held February 20-23, 2024 in Washington DC.... Read More
Written by: Julie Kim The U.S. Food and Drug Administration (“FDA”) recently approved the Edwards EVOQUE® Tricuspid Valve Replacement System (the “EVOQUE® system”) for... Read More